Rodenstock Reports 2024 Revenue Growth to EUR 512.4 Million and Adjusted EBITDA Increase

Rodenstock announced its financial results for the 2024 fiscal year, reporting consolidated net sales of EUR 512.4 million, a moderate increase from EUR 506.1 million in 2023. On a comparable basis, revenue rose by 1.2% despite ongoing macroeconomic challenges. The company achieved an adjusted EBITDA of EUR 128.6 million, representing a 5.1% increase compared to the previous year. Key drivers included strong demand for the B.I.G. VISION® biometric lens portfolio and MyCon™ lenses for children, which saw worldwide sales grow by 62% since their 2023 launch. Additionally, key account business excluding GrandVision grew by 11%. CEO Marcus Desimoni attributed these results to strategic product performance and efficiency improvements, noting a positive growth outlook for 2025.